UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 197

Sortiert nach

Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients

PloS one, 2015-08, Vol.10 (8), p.e0134395

2015

Link zum Volltext

Verfügbarkeit prüfen

Divergent preS Sequences in Virion-Associated Hepatitis B Virus Genomes and Subviral HBV Surface Antigen Particles From HBV e Antigen-Negative Patients

The Journal of infectious diseases, 2018-06, Vol.218 (1), p.114-123

2018

Link zum Volltext

Verfügbarkeit prüfen

Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants

Hepatology (Baltimore, Md.), 2019-09, Vol.70 (3), p.771-787

2019

Link zum Volltext

Verfügbarkeit prüfen

Macrophage-Derived Extracellular Vesicles Induce Long-Lasting Immunity Against Hepatitis C Virus Which Is Blunted by Polyunsaturated Fatty Acids

Frontiers in immunology, 2018-04, Vol.9, p.723-723

2018

Link zum Volltext

Verfügbarkeit prüfen

Deep Sequencing Reveals Mutagenic Effects of Ribavirin during Monotherapy of Hepatitis C Virus Genotype 1-Infected Patients

Journal of Virology, 2013-06, Vol.87 (11), p.6172-6181

2013

Link zum Volltext

Verfügbarkeit prüfen

Treatment and re-treatment results of HCV patients in the DAA era

PloS one, 2020-05, Vol.15 (5), p.e0232773-e0232773

2020

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic preparedness: DAA-resistant HCV variants in vitro and in vivo

Hepatology (Baltimore, Md.), 2023-08, Vol.78 (2), p.385-387

2023

Link zum Volltext

Verfügbarkeit prüfen

Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells

PLoS pathogens, 2011-05, Vol.7 (5), p.e1002045-e1002045

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C “true” late relapse beyond 48 weeks of sustained virologic response after direct acting antiviral therapy

Journal of hepatology, 2017-04, Vol.66 (4), p.862-863

2017

Link zum Volltext

Verfügbarkeit prüfen

Lightweight Techniques to Improve Generalization and Robustness of U-Net Based Networks for Pulmonary Lobe Segmentation

Bioengineering (Basel), 2024-01, Vol.11 (1), p.21

2024

Link zum Volltext

Verfügbarkeit prüfen

Interferon-free treatment choice according to baseline RASs leads to high SVR rates in HCV genotype 1 infected patients

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018-07, Vol.24 (7), p.524-530

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure

JHEP reports, 2024-03, Vol.6 (3), p.100994-100994, Article 100994

2024

Link zum Volltext

Verfügbarkeit prüfen

Reply to: “Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings”

Journal of hepatology, 2021-07, Vol.75 (1), p.254-255

2021

Link zum Volltext

Verfügbarkeit prüfen

Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy

PloS one, 2019-11, Vol.14 (11), p.e0224751-e0224751

2019

Link zum Volltext

Verfügbarkeit prüfen

SHARED: An International Collaboration to Unravel Hepatitis C Resistance

Viruses, 2021-08, Vol.13 (8), p.1580

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatic sarcoidosis: Clinical characteristics and outcome

JHEP reports, 2021-12, Vol.3 (6), p.100360-100360, Article 100360

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis

Journal of clinical medicine, 2020-09, Vol.9 (9), p.2702

2020

Link zum Volltext

Verfügbarkeit prüfen

Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels

International journal of molecular sciences, 2016-06, Vol.17 (6), p.922-922

2016

Link zum Volltext

Verfügbarkeit prüfen

Is Olfactory Testing a Useful Diagnostic Tool to Identify SARS-CoV-2 Infections Early? A Cross-Sectional and Longitudinal Analysis

Journal of clinical medicine, 2023-04, Vol.12 (9), p.3162

2023

Link zum Volltext

Verfügbarkeit prüfen

Primary Biliary Cholangitis (PBC)-Autoimmune Hepatitis (AIH) Variant Syndrome: Clinical Features, Response to Therapy and Long-Term Outcome

Journal of clinical medicine, 2023-11, Vol.12 (22), p.7047

2023

Link zum Volltext

Verfügbarkeit prüfen

Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years

JHEP reports, 2023-07, Vol.5 (7), p.100701-100701, Article 100701

2023

Link zum Volltext

Verfügbarkeit prüfen

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients

Clinical and molecular hepatology, 2019-03, Vol.25 (1), p.42-51

2019

Link zum Volltext

Verfügbarkeit prüfen

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillarassociated protein 4 in hepatitis C patients

Clinical and Molecular Hepatology, 2019, 25(1), , pp.42-51

2019

Link zum Volltext

Verfügbarkeit prüfen

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy

PloS one, 2016-06, Vol.11 (6), p.e0156731-e0156731

2016

Link zum Volltext

Verfügbarkeit prüfen

Exploring the future of Kafue National Park, Zambia: Scenario-based land use and land cover modelling to understand drivers and impacts of deforestation

Land use policy, 2023-03, Vol.126, p.106535, Article 106535

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 197

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(178)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(182)
Japanisch
(21)
Deutsch
(12)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(120)
Life Sciences & Biomedicine
(105)
Humans
(65)
Female
(39)
Male
(34)
Gastroenterology & Hepatology
(23)
Middle Aged
(23)
Patients
(23)
Adult
(21)
Hepatitis C
(21)
Hepatitis C Virus
(18)
Hepacivirus - Genetics
(17)
Aged
(15)
Animals
(15)
Oncology
(15)
Hepatitis
(14)
Antiviral Agents
(13)
Medicine
(13)
Proteins
(13)
Science & Technology - Other Topics
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients

Divergent preS Sequences in Virion-Associated Hepatitis B Virus Genomes and Subviral HBV Surface Antigen Particles From HBV e Antigen-Negative Patients

Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants

Macrophage-Derived Extracellular Vesicles Induce Long-Lasting Immunity Against Hepatitis C Virus Which Is Blunted by Polyunsaturated Fatty Acids

Deep Sequencing Reveals Mutagenic Effects of Ribavirin during Monotherapy of Hepatitis C Virus Genotype 1-Infected Patients

Treatment and re-treatment results of HCV patients in the DAA era

Therapeutic preparedness: DAA-resistant HCV variants in vitro and in vivo

Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells

Hepatitis C “true” late relapse beyond 48 weeks of sustained virologic response after direct acting antiviral therapy

Lightweight Techniques to Improve Generalization and Robustness of U-Net Based Networks for Pulmonary Lobe Segmentation

Interferon-free treatment choice according to baseline RASs leads to high SVR rates in HCV genotype 1 infected patients

Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure

Reply to: “Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings”

Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy

SHARED: An International Collaboration to Unravel Hepatitis C Resistance

Hepatic sarcoidosis: Clinical characteristics and outcome

Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis

Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels

Is Olfactory Testing a Useful Diagnostic Tool to Identify SARS-CoV-2 Infections Early? A Cross-Sectional and Longitudinal Analysis

Primary Biliary Cholangitis (PBC)-Autoimmune Hepatitis (AIH) Variant Syndrome: Clinical Features, Response to Therapy and Long-Term Outcome

Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillarassociated protein 4 in hepatitis C patients

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy

Exploring the future of Kafue National Park, Zambia: Scenario-based land use and land cover modelling to understand drivers and impacts of deforestation

Suchergebnisse filtern